AstraZeneca PLC (BUE:AZN)
ARS 42025 -50 (-0.12%) Market Cap: 219.46 Tn Enterprise Value: 245.64 Tn PE Ratio: 33.69 PB Ratio: 5.51 GF Score: 64/100

Full Year 2019 AstraZeneca PLC Earnings Call Transcript

Feb 14, 2020 / 12:00PM GMT
Release Date Price: ARS214.5
Operator

Good afternoon. Welcome, ladies and gentlemen, to AstraZeneca's presentation, conference call and webcast for investors and analysts. Before I hand over to Pascal Soriot in the auditorium, I'd like to read the safe harbor statement.

The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca. By their very nature, forward-looking statements involve risk and uncertainty, and results may differ materially from those expressed or implied by these forward-looking statements. The company undertakes no obligation to update forward-looking statements.

(Operator Instructions) I will now hand you over to Chief Executive Officer at AstraZeneca, Pascal Soriot, as the meeting is about to start.

Pascal Soriot
AstraZeneca PLC - CEO & Executive Director

Good morning, good afternoon, everybody. Hello, everyone. It's Pascal Soriot, I'm the CEO of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot